Cargando…

Early initiation of tolvaptan is associated with early discharge in patients with heart failure regardless of age

BACKGROUND: Elderly patients with heart failure (HF) have been observed to decrease activities of daily living (ADL) during hospitalization. Prevention of ADL decline from shortening of hospital stays is especially important in the elderly, because decreasing ADL is associated with poor prognosis. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiuchi, Shunsuke, Hisatake, Shinji, Kabuki, Takayuki, Oka, Takashi, Dobashi, Shintaro, Murakami, Yoshiki, Sano, Takahide, Ikeda, Takanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052442/ https://www.ncbi.nlm.nih.gov/pubmed/35488212 http://dx.doi.org/10.1186/s12872-022-02640-7

Ejemplares similares

Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients
por: Kiuchi, Shunsuke, et al.
Publicado: (2021)

Cardio-Ankle Vascular Index and C-Reactive Protein Are Useful Parameters for Identification of Ischemic Heart Disease in Acute Heart Failure Patients
por: Kiuchi, Shunsuke, et al.
Publicado: (2017)

The serum angiotensin-converting enzyme 2 and angiotensin-(1-7) concentrations after optimal therapy for acute decompensated heart failure with reduced ejection fraction
por: Hisatake, Shinji, et al.
Publicado: (2020)

Pulse Pressure and Upstroke Time Are Useful Parameters for the Diagnosis of Peripheral Artery Disease in Patients With Normal Ankle Brachial Index
por: Kiuchi, Shunsuke, et al.
Publicado: (2016)

Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia
por: Kiuchi, Shunsuke, et al.
Publicado: (2017)

Effectiveness of Fondaparinux in the Japanese Population with Acute Venous Thromboembolism -A Study Comparing Patients with and without Cancer-
por: Yamashita, Asami, et al.
Publicado: (2022)

Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness
por: Kiuchi, Shunsuke, et al.
Publicado: (2015)

Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure
por: Kiuchi, Shunsuke, et al.
Publicado: (2018)

Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure
por: Okada, Tomoaki, et al.
Publicado: (2023)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites
por: Hosui, Atsushi, et al.
Publicado: (2021)

Tolvaptan for the Treatment of Elephantiasis Nostras Verrucosa
por: Eda, Yuko, et al.
Publicado: (2019)

Evaluation of balloon pulmonary angioplasty using lung perfusion SPECT in patients with chronic thromboembolic pulmonary hypertension
por: Hashimoto, Hidenobu, et al.
Publicado: (2022)

Predictive factors for responders to tolvaptan in fluid management after cardiovascular surgery
por: Kido, Takashi, et al.
Publicado: (2016)

A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study
por: Hiruma, Shigenori, et al.
Publicado: (2021)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

Early Hospital Discharge Using Remote Monitoring for Patients Hospitalized for COVID-19, Regardless of Need for Home Oxygen Therapy: A Descriptive Study
por: Talha, Samy, et al.
Publicado: (2023)

Long-Term Tolvaptan Treatment in Refractory Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2019)

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
por: Gibson, Andrew, et al.
Publicado: (2020)

Tolvaptan Reduces Extracellular Fluid per Amount of Body Fluid Reduction Less Markedly than Conventional Diuretics
por: Iwatani, Hirotsugu, et al.
Publicado: (2022)

Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure
por: Niikura, Hiroki, et al.
Publicado: (2017)

Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis
por: Shang, Wenli, et al.
Publicado: (2022)

Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
por: Oka, Tatsufumi, et al.
Publicado: (2021)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis
por: Yin, Cong, et al.
Publicado: (2023)

Initiation and long-term use of tolvaptan for patients with worsening heart failure through hospital and clinic cooperation
por: Uemura, Yusuke, et al.
Publicado: (2021)

A Case of Non-Tachycardic Atrial Fibrillation Whose Left Ventricular Systolic Dysfunction Improved After Catheter Ablation
por: Yamashita, Asami, et al.
Publicado: (2023)

Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use
por: Mizuno, Hiroki, et al.
Publicado: (2022)

Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study
por: Shiba, Shunsuke, et al.
Publicado: (2020)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Tolvaptan and its potential in the treatment of hyponatremia
por: Dixon, Megan B, et al.
Publicado: (2008)

V2 Receptor Antagonist; Tolvaptan
por: Yi, Joo-Hark, et al.
Publicado: (2011)

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis
por: Iwamoto, Takuya, et al.
Publicado: (2016)

The management of polycystic liver disease by tolvaptan
por: Takenaka, Tsuneo, et al.
Publicado: (2020)

Prediction factors of tolvaptan effectiveness in patients with refractory ascites complicated with hepatocellular carcinoma
por: Imai, Michitaka, et al.
Publicado: (2020)

Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes
por: Shigiyama, Fumika, et al.
Publicado: (2019)

Early Statins after Intravenous or Endovascular Recanalization Is Beneficial Regardless of Timing, Intensity, and Stroke Mechanism
por: Jeong, Han-Gil, et al.
Publicado: (2017)

Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
por: Corre, Jill, et al.
Publicado: (2020)

Facilitated early discharge in Wandsworth
por: Firdosi, Mudasir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fscaemijl20ai4qgmt8ut861dh